Tuesday, December 09, 2014 7:21:58 AM
CALGARY, ALBERTA--(Marketwired - Dec. 9, 2014)
CALGARY, ALBERTA--(Marketwired - Dec. 9, 2014) - FLYHT Aerospace Solutions Ltd. ("FLYHT" or the "Company") (TSX VENTURE:FLY)(OTCQX:FLYLF) reported today it has received a Supplemental Type Certificate ("STC") for its Automated Flight Information Reporting System ("AFIRS™") 228 on the Boeing 767 - 200/300 series aircraft from the Federal Aviation Administration ("FAA") in the United States.
This certification will allow FLYHT customers to install AFIRS 228 on their 767 aircraft, including one new customer announced in a press release on November 13, 2014.
"FLYHT is pleased to add the AFIRS 228 STC for this popular aircraft type to the options available to our current and potential customers," stated Matt Bradley, President of FLYHT.
A STC constitutes regulatory approval to modify an aircraft's design while retaining airworthiness certification and is necessary to permit retrofit installation of aeronautical products such as AFIRS. A full list of FLYHT's STCs is available on the company's website.
About FLYHT Aerospace Solutions Ltd.
FLYHT provides proprietary technological products and services designed to reduce costs and improve efficiencies in the airline industry. The Company has patented and commercialized three products and associated services currently marketed to airlines, manufacturers and maintenance organizations around the world. Its premier technology, AFIRS™ UpTime™, allows airlines to monitor and manage aircraft operations anywhere, anytime, in real time. If an aircraft encounters an emergency, FLYHT's triggered data streaming mode, FLYHTStream™, automatically streams vital data, normally secured in the black box, to designated sites on the ground in real-time. The Dragon is FLYHT's latest product, a revolutionary light weight portable satellite communications device that blends existing FLYHT technology with that of the iPad.
AFIRS, UpTime, the Dragon, FLYHTStream and AeroQ are trademarks of FLYHT Aerospace Solutions Ltd.
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM